Terms: = Thyroid cancer AND ACSL3, PRO2194, 2181, ENSG00000123983, O95573, FACL3, ACS3
4 results:
1. Can preoperative modified systemic inflammation score (mSIS) be used to predict malignancy in persistent nondiagnostic thyroid nodules?
Ataş H; Korukluoğlu B; Çomçali B; Yakşi N; Saylam B; Tez M
Turk J Med Sci; 2021 Apr; 51(2):700-705. PubMed ID: 33550761
[TBL] [Abstract] [Full Text] [Related]
2. Lymph node metastasis in young and middle-aged papillary thyroid carcinoma patients: a SEER-based cohort study.
Liu Y; Wang Y; Zhao K; Li D; Chen Z; Jiang R; Wang X; He X
BMC Cancer; 2020 Mar; 20(1):181. PubMed ID: 32131769
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of Ultrasound Features of Primary Metastatic Papillary thyroid Carcinoma and Recurrent/Persistent Metastatic Cervical Lymph Nodes.
Xu JZ; Liang ZY; Wang XH; Li XY; Liu HF; Wu Q; Liu RY; Yang X; Zhu SL; Zhao RN; Lai XJ; Zhang XY; Xi XH; Zhang B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):675-681. PubMed ID: 29125111
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological characteristics of thyroid cancer in the federal state of Salzburg.
Rendl G; Rodrigues M; Schweighofer-Zwink G; Hutter J; Hittmair A; Zellinger B; Hauser-Kronberger C; Pirich C
Wien Klin Wochenschr; 2017 Aug; 129(15-16):540-544. PubMed ID: 28493027
[TBL] [Abstract] [Full Text] [Related]
